Literature DB >> 30416566

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker.

Maki Komiyama1, Hiromichi Wada1, Hajime Yamakage1, Noriko Asahara1, Sayaka Shimada1, Masaharu Akao1, Tatsuya Morimoto2, Yuko Takahashi1, Tatsuya Sawamura3, Koji Hasegawa1.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Inflammation; LOX Index; Smoking Cessation

Year:  2017        PMID: 30416566      PMCID: PMC6213008          DOI: 10.15420/ecr.2017:23:5

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


× No keyword cloud information.
  1 in total

Review 1.  LOX-1 in atherosclerotic disease.

Authors:  Tatsuya Sawamura; Ichiro Wakabayashi; Tomonori Okamura
Journal:  Clin Chim Acta       Date:  2014-11-22       Impact factor: 3.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.